Exclusion Criteria
receiving, or having received during the four weeks prior to study entry (signing of consent), treatment for their malignancy.
boolean
receiving, or having received during the four weeks prior to study entry (signing of consent), corticosteroids (at a dose > 10 mg prednisone/day or equivalent) for any reason.
boolean
a known hypersensitivity to azd6738 or any excipient of the product
boolean
treatment with any investigational medicinal product (imp) within 28 days prior to signing of consent
boolean
receiving, or having received, concomitant medications, herbal supplements and/or foods that significantly modulate cyp3a4 or pgp activity (wash out periods of two weeks, but three weeks for st. john's wort). note these include common azole antifungals, macrolide antibiotics
boolean
impaired hepatic function as demonstrated by any of the following laboratory values
text
glomerular filtration rate (gfr) < 50 ml/min, as assessed using the standard methodology at the investigating centre (i.e. cockroft-gault, mdrd or ckd-epi formulae, edta clearance or 24 h urine collection)
text
ast, alt, alp, bilirubin or renal function that, in the opinion of the investigator, is unstable or worsening
boolean
inr > 1.5 or other evidence of impaired hepatic synthesis function persisting (> 8 weeks) severe pancytopenia due to previous therapy rather than disease (anc < 0.5 x 109/l or platelets < 50 x 109/l) - to be confirmed via bone marrow biopsy, as part of normal clinical care, prior to signing of consent
boolean
cns involvement with malignancy
boolean
cardiac dysfunction as defined as: myocardial infarction within six months of study entry, nyha class ii/iii/iv heart failure, unstable angina, unstable cardiac arrhythmias or reduced lvef < 55%
text
any of the following cardiac criteria
text
any factors that increase the risk of qtc prolongation or risk of arrhythmic events such as heart failure, hypokalaemia, congenital long qt syndrome, immediate family history of long qt syndrome or unexplained sudden death under 40 years of age
boolean
e.g., carotid stenosis
boolean
patients with relative hypotension (< 100/60 mm/hg) or clinically relevant orthostatic hypotension, including a fall in blood pressure of >20mm/hg
boolean
uncontrolled hypertension requiring clinical intervention
boolean
any other malignancy which has been active or treated within the past three years, with the exception of cervical intra-epithelial neoplasia and non-melanoma skin cancer
boolean
refractory nausea and vomiting, chronic gastrointestinal diseases or previous significant bowel resection
boolean
patients with uncontrolled seizures
boolean
active infection requiring systemic antibiotics, antifungal or antiviral drugs
boolean
(e.g., severe copd, severe parkinson's disease, active inflammatory bowel disease)
boolean